nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—coronary artery disease—type 2 diabetes mellitus	0.364	1	CtDrD
Pitavastatin—HMGCR—type 2 diabetes mellitus	0.134	0.611	CbGaD
Pitavastatin—ABCC2—type 2 diabetes mellitus	0.0618	0.281	CbGaD
Pitavastatin—ALB—type 2 diabetes mellitus	0.0238	0.108	CbGaD
Pitavastatin—SLCO2B1—Tolbutamide—type 2 diabetes mellitus	0.0195	0.0637	CbGbCtD
Pitavastatin—SLCO1B3—Pioglitazone—type 2 diabetes mellitus	0.0194	0.0634	CbGbCtD
Pitavastatin—UGT1A3—Irbesartan—type 2 diabetes mellitus	0.019	0.0621	CbGbCtD
Pitavastatin—SLCO1B3—Valsartan—type 2 diabetes mellitus	0.0158	0.0517	CbGbCtD
Pitavastatin—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0125	0.0409	CbGbCtD
Pitavastatin—UGT1A3—Losartan—type 2 diabetes mellitus	0.0122	0.04	CbGbCtD
Pitavastatin—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.0113	0.0369	CbGbCtD
Pitavastatin—SLCO2B1—Glyburide—type 2 diabetes mellitus	0.0112	0.0366	CbGbCtD
Pitavastatin—ORM1—Nateglinide—type 2 diabetes mellitus	0.0112	0.0364	CbGbCtD
Pitavastatin—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.0104	0.0341	CbGbCtD
Pitavastatin—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.00922	0.0301	CbGbCtD
Pitavastatin—SLCO1B3—Losartan—type 2 diabetes mellitus	0.0091	0.0297	CbGbCtD
Pitavastatin—UGT2B7—Losartan—type 2 diabetes mellitus	0.00885	0.0289	CbGbCtD
Pitavastatin—ALB—Gliclazide—type 2 diabetes mellitus	0.00729	0.0238	CbGbCtD
Pitavastatin—ALB—Repaglinide—type 2 diabetes mellitus	0.00685	0.0224	CbGbCtD
Pitavastatin—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.00662	0.0216	CbGbCtD
Pitavastatin—ALB—Rosiglitazone—type 2 diabetes mellitus	0.00572	0.0187	CbGbCtD
Pitavastatin—SLCO1B1—Losartan—type 2 diabetes mellitus	0.0053	0.0173	CbGbCtD
Pitavastatin—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00529	0.0173	CbGbCtD
Pitavastatin—ABCC2—Glyburide—type 2 diabetes mellitus	0.00509	0.0166	CbGbCtD
Pitavastatin—ALB—Valsartan—type 2 diabetes mellitus	0.00505	0.0165	CbGbCtD
Pitavastatin—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00503	0.0164	CbGbCtD
Pitavastatin—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00479	0.0156	CbGbCtD
Pitavastatin—ALB—Nateglinide—type 2 diabetes mellitus	0.0047	0.0153	CbGbCtD
Pitavastatin—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00462	0.0151	CbGbCtD
Pitavastatin—ABCG2—Glyburide—type 2 diabetes mellitus	0.0046	0.015	CbGbCtD
Pitavastatin—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00448	0.0146	CbGbCtD
Pitavastatin—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00442	0.0144	CbGbCtD
Pitavastatin—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00427	0.0139	CbGbCtD
Pitavastatin—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00422	0.0138	CbGbCtD
Pitavastatin—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00393	0.0128	CbGbCtD
Pitavastatin—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00348	0.0114	CbGbCtD
Pitavastatin—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00334	0.0109	CbGbCtD
Pitavastatin—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00334	0.0109	CbGbCtD
Pitavastatin—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00324	0.0106	CbGbCtD
Pitavastatin—ALB—Glyburide—type 2 diabetes mellitus	0.00317	0.0104	CbGbCtD
Pitavastatin—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00308	0.0101	CbGbCtD
Pitavastatin—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00298	0.00972	CbGbCtD
Pitavastatin—ALB—Losartan—type 2 diabetes mellitus	0.0029	0.00947	CbGbCtD
Pitavastatin—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00272	0.00889	CbGbCtD
Pitavastatin—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00253	0.00826	CbGbCtD
Pitavastatin—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00243	0.00792	CbGbCtD
Pitavastatin—CYP2C8—Losartan—type 2 diabetes mellitus	0.00224	0.00732	CbGbCtD
Pitavastatin—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00223	0.00727	CbGbCtD
Pitavastatin—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00171	0.00558	CbGbCtD
Pitavastatin—ABCB1—Glyburide—type 2 diabetes mellitus	0.00166	0.00542	CbGbCtD
Pitavastatin—CYP2C9—Losartan—type 2 diabetes mellitus	0.00156	0.00511	CbGbCtD
Pitavastatin—ABCB1—Losartan—type 2 diabetes mellitus	0.00152	0.00496	CbGbCtD
Pitavastatin—Rosuvastatin—HMGCR—type 2 diabetes mellitus	0.000488	0.217	CrCbGaD
Pitavastatin—Atorvastatin—DPP4—type 2 diabetes mellitus	0.000404	0.18	CrCbGaD
Pitavastatin—Fluvastatin—HMGCR—type 2 diabetes mellitus	0.000395	0.176	CrCbGaD
Pitavastatin—Atorvastatin—HMGCR—type 2 diabetes mellitus	0.000344	0.153	CrCbGaD
Pitavastatin—UGT1A3—liver—type 2 diabetes mellitus	0.000245	0.0529	CbGeAlD
Pitavastatin—SLC10A1—kidney—type 2 diabetes mellitus	0.000237	0.0513	CbGeAlD
Pitavastatin—HMGCR—islet of Langerhans—type 2 diabetes mellitus	0.000232	0.0501	CbGeAlD
Pitavastatin—UGT2B7—kidney—type 2 diabetes mellitus	0.000222	0.048	CbGeAlD
Pitavastatin—HMGCR—nephron tubule—type 2 diabetes mellitus	0.000187	0.0404	CbGeAlD
Pitavastatin—SLCO1B3—liver—type 2 diabetes mellitus	0.000172	0.0371	CbGeAlD
Pitavastatin—HMGCR—cardiovascular system—type 2 diabetes mellitus	0.000168	0.0363	CbGeAlD
Pitavastatin—HMGCR—kidney—type 2 diabetes mellitus	0.000164	0.0355	CbGeAlD
Pitavastatin—HMGCR—pancreas—type 2 diabetes mellitus	0.000163	0.0352	CbGeAlD
Pitavastatin—HMGCR—cortex of kidney—type 2 diabetes mellitus	0.00016	0.0345	CbGeAlD
Pitavastatin—Atorvastatin—ABCC2—type 2 diabetes mellitus	0.000158	0.0704	CrCbGaD
Pitavastatin—SLCO1B1—kidney—type 2 diabetes mellitus	0.000157	0.034	CbGeAlD
Pitavastatin—SLC10A1—liver—type 2 diabetes mellitus	0.00015	0.0324	CbGeAlD
Pitavastatin—HMGCR—adipose tissue—type 2 diabetes mellitus	0.000148	0.032	CbGeAlD
Pitavastatin—UGT2B7—liver—type 2 diabetes mellitus	0.000141	0.0304	CbGeAlD
Pitavastatin—SLCO2B1—kidney—type 2 diabetes mellitus	0.000139	0.0301	CbGeAlD
Pitavastatin—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000136	0.0293	CbGeAlD
Pitavastatin—SLCO2B1—adipose tissue—type 2 diabetes mellitus	0.000125	0.0271	CbGeAlD
Pitavastatin—Fluvastatin—CYP1A2—type 2 diabetes mellitus	0.000121	0.0539	CrCbGaD
Pitavastatin—ABCC2—kidney—type 2 diabetes mellitus	0.000119	0.0258	CbGeAlD
Pitavastatin—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000116	0.0251	CbGeAlD
Pitavastatin—Confusional state—Glyburide—type 2 diabetes mellitus	0.000115	0.00193	CcSEcCtD
Pitavastatin—Influenza—Ramipril—type 2 diabetes mellitus	0.000114	0.00192	CcSEcCtD
Pitavastatin—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000113	0.00191	CcSEcCtD
Pitavastatin—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000113	0.00191	CcSEcCtD
Pitavastatin—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000113	0.0019	CcSEcCtD
Pitavastatin—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.000113	0.0019	CcSEcCtD
Pitavastatin—Malaise—Gliclazide—type 2 diabetes mellitus	0.000113	0.00189	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000113	0.00189	CcSEcCtD
Pitavastatin—Rash—Repaglinide—type 2 diabetes mellitus	0.000112	0.00189	CcSEcCtD
Pitavastatin—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000112	0.00189	CcSEcCtD
Pitavastatin—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000112	0.00189	CcSEcCtD
Pitavastatin—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000112	0.00189	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000112	0.00189	CcSEcCtD
Pitavastatin—Headache—Repaglinide—type 2 diabetes mellitus	0.000112	0.00188	CcSEcCtD
Pitavastatin—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000111	0.00187	CcSEcCtD
Pitavastatin—Back pain—Valsartan—type 2 diabetes mellitus	0.000111	0.00187	CcSEcCtD
Pitavastatin—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.00011	0.00186	CcSEcCtD
Pitavastatin—Back pain—Orlistat—type 2 diabetes mellitus	0.00011	0.00185	CcSEcCtD
Pitavastatin—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.00011	0.00184	CcSEcCtD
Pitavastatin—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000109	0.00184	CcSEcCtD
Pitavastatin—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000109	0.00184	CcSEcCtD
Pitavastatin—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000109	0.00183	CcSEcCtD
Pitavastatin—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000109	0.00183	CcSEcCtD
Pitavastatin—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000109	0.00183	CcSEcCtD
Pitavastatin—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000109	0.00183	CcSEcCtD
Pitavastatin—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000109	0.00182	CcSEcCtD
Pitavastatin—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000107	0.0018	CcSEcCtD
Pitavastatin—Hepatitis—Losartan—type 2 diabetes mellitus	0.000107	0.00179	CcSEcCtD
Pitavastatin—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000106	0.00179	CcSEcCtD
Pitavastatin—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000106	0.00179	CcSEcCtD
Pitavastatin—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000106	0.00179	CcSEcCtD
Pitavastatin—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000106	0.00179	CcSEcCtD
Pitavastatin—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000106	0.00179	CcSEcCtD
Pitavastatin—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000106	0.00178	CcSEcCtD
Pitavastatin—Nausea—Repaglinide—type 2 diabetes mellitus	0.000106	0.00178	CcSEcCtD
Pitavastatin—Asthenia—Glipizide—type 2 diabetes mellitus	0.000106	0.00178	CcSEcCtD
Pitavastatin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000106	0.00178	CcSEcCtD
Pitavastatin—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000105	0.00177	CcSEcCtD
Pitavastatin—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000105	0.00177	CcSEcCtD
Pitavastatin—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000105	0.00177	CcSEcCtD
Pitavastatin—Pruritus—Glipizide—type 2 diabetes mellitus	0.000104	0.00176	CcSEcCtD
Pitavastatin—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000104	0.00175	CcSEcCtD
Pitavastatin—HMGCR—liver—type 2 diabetes mellitus	0.000104	0.0224	CbGeAlD
Pitavastatin—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000103	0.00174	CcSEcCtD
Pitavastatin—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000103	0.00173	CcSEcCtD
Pitavastatin—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000102	0.00172	CcSEcCtD
Pitavastatin—Malaise—Orlistat—type 2 diabetes mellitus	0.000102	0.00172	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000102	0.00171	CcSEcCtD
Pitavastatin—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000101	0.00171	CcSEcCtD
Pitavastatin—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000101	0.00171	CcSEcCtD
Pitavastatin—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000101	0.0017	CcSEcCtD
Pitavastatin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000101	0.0017	CcSEcCtD
Pitavastatin—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000101	0.00169	CcSEcCtD
Pitavastatin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.0001	0.00168	CcSEcCtD
Pitavastatin—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.0001	0.00168	CcSEcCtD
Pitavastatin—SLCO1B1—liver—type 2 diabetes mellitus	9.95e-05	0.0215	CbGeAlD
Pitavastatin—Jaundice—Ramipril—type 2 diabetes mellitus	9.93e-05	0.00167	CcSEcCtD
Pitavastatin—Rosuvastatin—CYP3A4—type 2 diabetes mellitus	9.91e-05	0.0441	CrCbGaD
Pitavastatin—ABCG2—nephron tubule—type 2 diabetes mellitus	9.9e-05	0.0214	CbGeAlD
Pitavastatin—Asthenia—Glimepiride—type 2 diabetes mellitus	9.88e-05	0.00166	CcSEcCtD
Pitavastatin—Urticaria—Bromocriptine—type 2 diabetes mellitus	9.87e-05	0.00166	CcSEcCtD
Pitavastatin—Asthenia—Sitagliptin—type 2 diabetes mellitus	9.85e-05	0.00166	CcSEcCtD
Pitavastatin—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	9.82e-05	0.00165	CcSEcCtD
Pitavastatin—Arthralgia—Valsartan—type 2 diabetes mellitus	9.77e-05	0.00164	CcSEcCtD
Pitavastatin—Myalgia—Valsartan—type 2 diabetes mellitus	9.77e-05	0.00164	CcSEcCtD
Pitavastatin—Dizziness—Glipizide—type 2 diabetes mellitus	9.76e-05	0.00164	CcSEcCtD
Pitavastatin—Pruritus—Glimepiride—type 2 diabetes mellitus	9.74e-05	0.00164	CcSEcCtD
Pitavastatin—Ill-defined disorder—Metformin—type 2 diabetes mellitus	9.7e-05	0.00163	CcSEcCtD
Pitavastatin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	9.67e-05	0.00163	CcSEcCtD
Pitavastatin—Myalgia—Orlistat—type 2 diabetes mellitus	9.66e-05	0.00162	CcSEcCtD
Pitavastatin—Discomfort—Orlistat—type 2 diabetes mellitus	9.54e-05	0.0016	CcSEcCtD
Pitavastatin—Muscle spasms—Irbesartan—type 2 diabetes mellitus	9.49e-05	0.0016	CcSEcCtD
Pitavastatin—Malaise—Metformin—type 2 diabetes mellitus	9.43e-05	0.00159	CcSEcCtD
Pitavastatin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	9.42e-05	0.00158	CcSEcCtD
Pitavastatin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	9.39e-05	0.00158	CcSEcCtD
Pitavastatin—Feeling abnormal—Glyburide—type 2 diabetes mellitus	9.36e-05	0.00157	CcSEcCtD
Pitavastatin—Dizziness—Pioglitazone—type 2 diabetes mellitus	9.35e-05	0.00157	CcSEcCtD
Pitavastatin—Rash—Glipizide—type 2 diabetes mellitus	9.31e-05	0.00156	CcSEcCtD
Pitavastatin—Dermatitis—Glipizide—type 2 diabetes mellitus	9.3e-05	0.00156	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	9.29e-05	0.00156	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	9.29e-05	0.00156	CcSEcCtD
Pitavastatin—Headache—Glipizide—type 2 diabetes mellitus	9.25e-05	0.00155	CcSEcCtD
Pitavastatin—Insomnia—Gliclazide—type 2 diabetes mellitus	9.22e-05	0.00155	CcSEcCtD
Pitavastatin—ORM1—liver—type 2 diabetes mellitus	9.18e-05	0.0198	CbGeAlD
Pitavastatin—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	9.15e-05	0.00154	CcSEcCtD
Pitavastatin—Hepatitis—Ramipril—type 2 diabetes mellitus	9.15e-05	0.00154	CcSEcCtD
Pitavastatin—Dizziness—Glimepiride—type 2 diabetes mellitus	9.11e-05	0.00153	CcSEcCtD
Pitavastatin—Dizziness—Sitagliptin—type 2 diabetes mellitus	9.08e-05	0.00153	CcSEcCtD
Pitavastatin—Urticaria—Glyburide—type 2 diabetes mellitus	9.02e-05	0.00152	CcSEcCtD
Pitavastatin—Back pain—Losartan—type 2 diabetes mellitus	8.98e-05	0.00151	CcSEcCtD
Pitavastatin—Abdominal pain—Glyburide—type 2 diabetes mellitus	8.98e-05	0.00151	CcSEcCtD
Pitavastatin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	8.98e-05	0.00151	CcSEcCtD
Pitavastatin—CYP2C8—kidney—type 2 diabetes mellitus	8.95e-05	0.0193	CbGeAlD
Pitavastatin—Muscle spasms—Losartan—type 2 diabetes mellitus	8.93e-05	0.0015	CcSEcCtD
Pitavastatin—Asthenia—Bromocriptine—type 2 diabetes mellitus	8.91e-05	0.0015	CcSEcCtD
Pitavastatin—Myalgia—Metformin—type 2 diabetes mellitus	8.9e-05	0.0015	CcSEcCtD
Pitavastatin—Malaise—Irbesartan—type 2 diabetes mellitus	8.9e-05	0.0015	CcSEcCtD
Pitavastatin—Headache—Pioglitazone—type 2 diabetes mellitus	8.86e-05	0.00149	CcSEcCtD
Pitavastatin—SLCO2B1—liver—type 2 diabetes mellitus	8.8e-05	0.019	CbGeAlD
Pitavastatin—Discomfort—Metformin—type 2 diabetes mellitus	8.79e-05	0.00148	CcSEcCtD
Pitavastatin—Fatigue—Gliclazide—type 2 diabetes mellitus	8.79e-05	0.00148	CcSEcCtD
Pitavastatin—Nausea—Glipizide—type 2 diabetes mellitus	8.77e-05	0.00147	CcSEcCtD
Pitavastatin—Constipation—Gliclazide—type 2 diabetes mellitus	8.72e-05	0.00147	CcSEcCtD
Pitavastatin—Rash—Glimepiride—type 2 diabetes mellitus	8.68e-05	0.00146	CcSEcCtD
Pitavastatin—Dermatitis—Glimepiride—type 2 diabetes mellitus	8.68e-05	0.00146	CcSEcCtD
Pitavastatin—Rash—Sitagliptin—type 2 diabetes mellitus	8.66e-05	0.00146	CcSEcCtD
Pitavastatin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	8.65e-05	0.00145	CcSEcCtD
Pitavastatin—Rosuvastatin—ALB—type 2 diabetes mellitus	8.65e-05	0.0385	CrCbGaD
Pitavastatin—Headache—Glimepiride—type 2 diabetes mellitus	8.63e-05	0.00145	CcSEcCtD
Pitavastatin—Ill-defined disorder—Losartan—type 2 diabetes mellitus	8.62e-05	0.00145	CcSEcCtD
Pitavastatin—Headache—Sitagliptin—type 2 diabetes mellitus	8.6e-05	0.00145	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	8.54e-05	0.00144	CcSEcCtD
Pitavastatin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	8.5e-05	0.00143	CcSEcCtD
Pitavastatin—Insomnia—Valsartan—type 2 diabetes mellitus	8.48e-05	0.00143	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	8.44e-05	0.00142	CcSEcCtD
Pitavastatin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	8.4e-05	0.00141	CcSEcCtD
Pitavastatin—Arthralgia—Irbesartan—type 2 diabetes mellitus	8.4e-05	0.00141	CcSEcCtD
Pitavastatin—Myalgia—Irbesartan—type 2 diabetes mellitus	8.4e-05	0.00141	CcSEcCtD
Pitavastatin—Insomnia—Orlistat—type 2 diabetes mellitus	8.37e-05	0.00141	CcSEcCtD
Pitavastatin—Malaise—Losartan—type 2 diabetes mellitus	8.37e-05	0.00141	CcSEcCtD
Pitavastatin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	8.37e-05	0.00141	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	8.34e-05	0.0014	CcSEcCtD
Pitavastatin—Discomfort—Irbesartan—type 2 diabetes mellitus	8.3e-05	0.0014	CcSEcCtD
Pitavastatin—Dyspepsia—Valsartan—type 2 diabetes mellitus	8.25e-05	0.00139	CcSEcCtD
Pitavastatin—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.22e-05	0.00138	CcSEcCtD
Pitavastatin—Nausea—Glimepiride—type 2 diabetes mellitus	8.18e-05	0.00138	CcSEcCtD
Pitavastatin—Nausea—Sitagliptin—type 2 diabetes mellitus	8.15e-05	0.00137	CcSEcCtD
Pitavastatin—Dyspepsia—Orlistat—type 2 diabetes mellitus	8.15e-05	0.00137	CcSEcCtD
Pitavastatin—Asthenia—Glyburide—type 2 diabetes mellitus	8.15e-05	0.00137	CcSEcCtD
Pitavastatin—CYP2C9—cardiovascular system—type 2 diabetes mellitus	8.12e-05	0.0175	CbGeAlD
Pitavastatin—Urticaria—Gliclazide—type 2 diabetes mellitus	8.1e-05	0.00136	CcSEcCtD
Pitavastatin—Fatigue—Valsartan—type 2 diabetes mellitus	8.08e-05	0.00136	CcSEcCtD
Pitavastatin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	8.06e-05	0.00136	CcSEcCtD
Pitavastatin—ALB—liver—type 2 diabetes mellitus	8.05e-05	0.0174	CbGeAlD
Pitavastatin—Pruritus—Glyburide—type 2 diabetes mellitus	8.04e-05	0.00135	CcSEcCtD
Pitavastatin—Fluvastatin—CYP3A4—type 2 diabetes mellitus	8.02e-05	0.0357	CrCbGaD
Pitavastatin—Constipation—Valsartan—type 2 diabetes mellitus	8.01e-05	0.00135	CcSEcCtD
Pitavastatin—Fatigue—Orlistat—type 2 diabetes mellitus	7.98e-05	0.00134	CcSEcCtD
Pitavastatin—Myalgia—Losartan—type 2 diabetes mellitus	7.91e-05	0.00133	CcSEcCtD
Pitavastatin—Arthralgia—Losartan—type 2 diabetes mellitus	7.91e-05	0.00133	CcSEcCtD
Pitavastatin—ABCG2—adipose tissue—type 2 diabetes mellitus	7.84e-05	0.0169	CbGeAlD
Pitavastatin—Rash—Bromocriptine—type 2 diabetes mellitus	7.83e-05	0.00132	CcSEcCtD
Pitavastatin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.83e-05	0.00132	CcSEcCtD
Pitavastatin—Discomfort—Losartan—type 2 diabetes mellitus	7.81e-05	0.00131	CcSEcCtD
Pitavastatin—Headache—Bromocriptine—type 2 diabetes mellitus	7.78e-05	0.00131	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.77e-05	0.00131	CcSEcCtD
Pitavastatin—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.77e-05	0.00131	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.66e-05	0.00129	CcSEcCtD
Pitavastatin—Muscle spasms—Ramipril—type 2 diabetes mellitus	7.66e-05	0.00129	CcSEcCtD
Pitavastatin—Confusional state—Losartan—type 2 diabetes mellitus	7.64e-05	0.00128	CcSEcCtD
Pitavastatin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	7.63e-05	0.00128	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.57e-05	0.00127	CcSEcCtD
Pitavastatin—ABCC2—liver—type 2 diabetes mellitus	7.54e-05	0.0163	CbGeAlD
Pitavastatin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	7.51e-05	0.00126	CcSEcCtD
Pitavastatin—Dyspepsia—Metformin—type 2 diabetes mellitus	7.51e-05	0.00126	CcSEcCtD
Pitavastatin—Urticaria—Valsartan—type 2 diabetes mellitus	7.44e-05	0.00125	CcSEcCtD
Pitavastatin—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.41e-05	0.00125	CcSEcCtD
Pitavastatin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	7.39e-05	0.00124	CcSEcCtD
Pitavastatin—Nausea—Bromocriptine—type 2 diabetes mellitus	7.38e-05	0.00124	CcSEcCtD
Pitavastatin—Fatigue—Metformin—type 2 diabetes mellitus	7.36e-05	0.00124	CcSEcCtD
Pitavastatin—Urticaria—Orlistat—type 2 diabetes mellitus	7.36e-05	0.00124	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.34e-05	0.00123	CcSEcCtD
Pitavastatin—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.32e-05	0.00123	CcSEcCtD
Pitavastatin—Asthenia—Gliclazide—type 2 diabetes mellitus	7.32e-05	0.00123	CcSEcCtD
Pitavastatin—Constipation—Metformin—type 2 diabetes mellitus	7.3e-05	0.00123	CcSEcCtD
Pitavastatin—Pruritus—Gliclazide—type 2 diabetes mellitus	7.22e-05	0.00121	CcSEcCtD
Pitavastatin—Malaise—Ramipril—type 2 diabetes mellitus	7.18e-05	0.00121	CcSEcCtD
Pitavastatin—Rash—Glyburide—type 2 diabetes mellitus	7.16e-05	0.0012	CcSEcCtD
Pitavastatin—Dermatitis—Glyburide—type 2 diabetes mellitus	7.16e-05	0.0012	CcSEcCtD
Pitavastatin—Headache—Glyburide—type 2 diabetes mellitus	7.12e-05	0.0012	CcSEcCtD
Pitavastatin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	7.09e-05	0.00119	CcSEcCtD
Pitavastatin—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.03e-05	0.00118	CcSEcCtD
Pitavastatin—Atorvastatin—CYP3A4—type 2 diabetes mellitus	6.98e-05	0.0311	CrCbGaD
Pitavastatin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.98e-05	0.00117	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.98e-05	0.00117	CcSEcCtD
Pitavastatin—Fatigue—Irbesartan—type 2 diabetes mellitus	6.94e-05	0.00117	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.9e-05	0.00116	CcSEcCtD
Pitavastatin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.9e-05	0.00116	CcSEcCtD
Pitavastatin—Constipation—Irbesartan—type 2 diabetes mellitus	6.89e-05	0.00116	CcSEcCtD
Pitavastatin—Insomnia—Losartan—type 2 diabetes mellitus	6.85e-05	0.00115	CcSEcCtD
Pitavastatin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.82e-05	0.00115	CcSEcCtD
Pitavastatin—Urticaria—Metformin—type 2 diabetes mellitus	6.78e-05	0.00114	CcSEcCtD
Pitavastatin—Myalgia—Ramipril—type 2 diabetes mellitus	6.78e-05	0.00114	CcSEcCtD
Pitavastatin—Arthralgia—Ramipril—type 2 diabetes mellitus	6.78e-05	0.00114	CcSEcCtD
Pitavastatin—Nausea—Glyburide—type 2 diabetes mellitus	6.75e-05	0.00113	CcSEcCtD
Pitavastatin—Abdominal pain—Metformin—type 2 diabetes mellitus	6.75e-05	0.00113	CcSEcCtD
Pitavastatin—Dizziness—Gliclazide—type 2 diabetes mellitus	6.74e-05	0.00113	CcSEcCtD
Pitavastatin—Asthenia—Valsartan—type 2 diabetes mellitus	6.72e-05	0.00113	CcSEcCtD
Pitavastatin—Discomfort—Ramipril—type 2 diabetes mellitus	6.7e-05	0.00113	CcSEcCtD
Pitavastatin—Dyspepsia—Losartan—type 2 diabetes mellitus	6.67e-05	0.00112	CcSEcCtD
Pitavastatin—Asthenia—Orlistat—type 2 diabetes mellitus	6.64e-05	0.00112	CcSEcCtD
Pitavastatin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.64e-05	0.00112	CcSEcCtD
Pitavastatin—Pruritus—Valsartan—type 2 diabetes mellitus	6.63e-05	0.00111	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.58e-05	0.00111	CcSEcCtD
Pitavastatin—Confusional state—Ramipril—type 2 diabetes mellitus	6.55e-05	0.0011	CcSEcCtD
Pitavastatin—Pruritus—Orlistat—type 2 diabetes mellitus	6.55e-05	0.0011	CcSEcCtD
Pitavastatin—Fatigue—Losartan—type 2 diabetes mellitus	6.53e-05	0.0011	CcSEcCtD
Pitavastatin—Constipation—Losartan—type 2 diabetes mellitus	6.48e-05	0.00109	CcSEcCtD
Pitavastatin—Rash—Gliclazide—type 2 diabetes mellitus	6.43e-05	0.00108	CcSEcCtD
Pitavastatin—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.42e-05	0.00108	CcSEcCtD
Pitavastatin—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.41e-05	0.00108	CcSEcCtD
Pitavastatin—Urticaria—Irbesartan—type 2 diabetes mellitus	6.4e-05	0.00108	CcSEcCtD
Pitavastatin—Headache—Gliclazide—type 2 diabetes mellitus	6.39e-05	0.00107	CcSEcCtD
Pitavastatin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.37e-05	0.00107	CcSEcCtD
Pitavastatin—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.34e-05	0.00107	CcSEcCtD
Pitavastatin—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.25e-05	0.00105	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.2e-05	0.00104	CcSEcCtD
Pitavastatin—Dizziness—Valsartan—type 2 diabetes mellitus	6.2e-05	0.00104	CcSEcCtD
Pitavastatin—Dizziness—Orlistat—type 2 diabetes mellitus	6.12e-05	0.00103	CcSEcCtD
Pitavastatin—Asthenia—Metformin—type 2 diabetes mellitus	6.12e-05	0.00103	CcSEcCtD
Pitavastatin—ABCB1—islet of Langerhans—type 2 diabetes mellitus	6.06e-05	0.0131	CbGeAlD
Pitavastatin—Nausea—Gliclazide—type 2 diabetes mellitus	6.06e-05	0.00102	CcSEcCtD
Pitavastatin—Pruritus—Metformin—type 2 diabetes mellitus	6.04e-05	0.00102	CcSEcCtD
Pitavastatin—Urticaria—Losartan—type 2 diabetes mellitus	6.02e-05	0.00101	CcSEcCtD
Pitavastatin—Abdominal pain—Losartan—type 2 diabetes mellitus	5.99e-05	0.00101	CcSEcCtD
Pitavastatin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.93e-05	0.000998	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000995	CcSEcCtD
Pitavastatin—Rash—Valsartan—type 2 diabetes mellitus	5.91e-05	0.000993	CcSEcCtD
Pitavastatin—Dermatitis—Valsartan—type 2 diabetes mellitus	5.9e-05	0.000992	CcSEcCtD
Pitavastatin—Insomnia—Ramipril—type 2 diabetes mellitus	5.88e-05	0.000988	CcSEcCtD
Pitavastatin—Headache—Valsartan—type 2 diabetes mellitus	5.87e-05	0.000987	CcSEcCtD
Pitavastatin—Diarrhoea—Metformin—type 2 diabetes mellitus	5.84e-05	0.000982	CcSEcCtD
Pitavastatin—Rash—Orlistat—type 2 diabetes mellitus	5.84e-05	0.000982	CcSEcCtD
Pitavastatin—Dermatitis—Orlistat—type 2 diabetes mellitus	5.83e-05	0.000981	CcSEcCtD
Pitavastatin—Headache—Orlistat—type 2 diabetes mellitus	5.8e-05	0.000975	CcSEcCtD
Pitavastatin—Asthenia—Irbesartan—type 2 diabetes mellitus	5.78e-05	0.000971	CcSEcCtD
Pitavastatin—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.72e-05	0.000962	CcSEcCtD
Pitavastatin—Pruritus—Irbesartan—type 2 diabetes mellitus	5.7e-05	0.000958	CcSEcCtD
Pitavastatin—CYP2C8—liver—type 2 diabetes mellitus	5.66e-05	0.0122	CbGeAlD
Pitavastatin—Dizziness—Metformin—type 2 diabetes mellitus	5.64e-05	0.000949	CcSEcCtD
Pitavastatin—Fatigue—Ramipril—type 2 diabetes mellitus	5.6e-05	0.000942	CcSEcCtD
Pitavastatin—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.58e-05	0.000939	CcSEcCtD
Pitavastatin—Nausea—Valsartan—type 2 diabetes mellitus	5.57e-05	0.000936	CcSEcCtD
Pitavastatin—Constipation—Ramipril—type 2 diabetes mellitus	5.56e-05	0.000934	CcSEcCtD
Pitavastatin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.51e-05	0.000926	CcSEcCtD
Pitavastatin—ABCG2—liver—type 2 diabetes mellitus	5.5e-05	0.0119	CbGeAlD
Pitavastatin—Nausea—Orlistat—type 2 diabetes mellitus	5.5e-05	0.000925	CcSEcCtD
Pitavastatin—Asthenia—Losartan—type 2 diabetes mellitus	5.44e-05	0.000914	CcSEcCtD
Pitavastatin—Rash—Metformin—type 2 diabetes mellitus	5.38e-05	0.000905	CcSEcCtD
Pitavastatin—Dermatitis—Metformin—type 2 diabetes mellitus	5.38e-05	0.000904	CcSEcCtD
Pitavastatin—Pruritus—Losartan—type 2 diabetes mellitus	5.36e-05	0.000902	CcSEcCtD
Pitavastatin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.35e-05	0.0009	CcSEcCtD
Pitavastatin—Headache—Metformin—type 2 diabetes mellitus	5.35e-05	0.000899	CcSEcCtD
Pitavastatin—Dizziness—Irbesartan—type 2 diabetes mellitus	5.33e-05	0.000895	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000893	CcSEcCtD
Pitavastatin—Diarrhoea—Losartan—type 2 diabetes mellitus	5.19e-05	0.000872	CcSEcCtD
Pitavastatin—ABCB1—retina—type 2 diabetes mellitus	5.18e-05	0.0112	CbGeAlD
Pitavastatin—Urticaria—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000868	CcSEcCtD
Pitavastatin—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000864	CcSEcCtD
Pitavastatin—Rash—Irbesartan—type 2 diabetes mellitus	5.08e-05	0.000854	CcSEcCtD
Pitavastatin—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.07e-05	0.000853	CcSEcCtD
Pitavastatin—Nausea—Metformin—type 2 diabetes mellitus	5.07e-05	0.000852	CcSEcCtD
Pitavastatin—Headache—Irbesartan—type 2 diabetes mellitus	5.04e-05	0.000848	CcSEcCtD
Pitavastatin—CYP2C9—liver—type 2 diabetes mellitus	5.02e-05	0.0108	CbGeAlD
Pitavastatin—Dizziness—Losartan—type 2 diabetes mellitus	5.01e-05	0.000843	CcSEcCtD
Pitavastatin—ABCB1—nephron tubule—type 2 diabetes mellitus	4.88e-05	0.0105	CbGeAlD
Pitavastatin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.79e-05	0.000805	CcSEcCtD
Pitavastatin—Nausea—Irbesartan—type 2 diabetes mellitus	4.78e-05	0.000804	CcSEcCtD
Pitavastatin—Rash—Losartan—type 2 diabetes mellitus	4.78e-05	0.000803	CcSEcCtD
Pitavastatin—Dermatitis—Losartan—type 2 diabetes mellitus	4.77e-05	0.000803	CcSEcCtD
Pitavastatin—Headache—Losartan—type 2 diabetes mellitus	4.75e-05	0.000798	CcSEcCtD
Pitavastatin—Asthenia—Ramipril—type 2 diabetes mellitus	4.66e-05	0.000784	CcSEcCtD
Pitavastatin—Pruritus—Ramipril—type 2 diabetes mellitus	4.6e-05	0.000773	CcSEcCtD
Pitavastatin—Nausea—Losartan—type 2 diabetes mellitus	4.5e-05	0.000757	CcSEcCtD
Pitavastatin—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.45e-05	0.000748	CcSEcCtD
Pitavastatin—ABCB1—cardiovascular system—type 2 diabetes mellitus	4.39e-05	0.00947	CbGeAlD
Pitavastatin—Dizziness—Ramipril—type 2 diabetes mellitus	4.3e-05	0.000723	CcSEcCtD
Pitavastatin—ABCB1—kidney—type 2 diabetes mellitus	4.29e-05	0.00926	CbGeAlD
Pitavastatin—ABCB1—pancreas—type 2 diabetes mellitus	4.26e-05	0.0092	CbGeAlD
Pitavastatin—ABCB1—cortex of kidney—type 2 diabetes mellitus	4.18e-05	0.00902	CbGeAlD
Pitavastatin—Rash—Ramipril—type 2 diabetes mellitus	4.1e-05	0.000689	CcSEcCtD
Pitavastatin—Dermatitis—Ramipril—type 2 diabetes mellitus	4.09e-05	0.000688	CcSEcCtD
Pitavastatin—Headache—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000684	CcSEcCtD
Pitavastatin—ABCB1—adipose tissue—type 2 diabetes mellitus	3.87e-05	0.00835	CbGeAlD
Pitavastatin—Nausea—Ramipril—type 2 diabetes mellitus	3.86e-05	0.000649	CcSEcCtD
Pitavastatin—ABCB1—liver—type 2 diabetes mellitus	2.71e-05	0.00586	CbGeAlD
Pitavastatin—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	2.42e-06	5.58e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.42e-06	5.58e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	2.42e-06	5.58e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	2.42e-06	5.58e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	2.42e-06	5.58e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.41e-06	5.56e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.4e-06	5.55e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—LIPC—type 2 diabetes mellitus	2.4e-06	5.54e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—HBA1—type 2 diabetes mellitus	2.4e-06	5.54e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GCK—type 2 diabetes mellitus	2.4e-06	5.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	2.4e-06	5.54e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—NOS3—type 2 diabetes mellitus	2.4e-06	5.53e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3R1—type 2 diabetes mellitus	2.4e-06	5.53e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	2.39e-06	5.51e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.38e-06	5.49e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	2.38e-06	5.49e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—LPL—type 2 diabetes mellitus	2.38e-06	5.48e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	2.37e-06	5.48e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	2.36e-06	5.45e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	2.36e-06	5.44e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	2.35e-06	5.41e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	2.33e-06	5.38e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTGS2—type 2 diabetes mellitus	2.33e-06	5.37e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ADCY5—type 2 diabetes mellitus	2.33e-06	5.37e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—GPX1—type 2 diabetes mellitus	2.32e-06	5.35e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CETP—type 2 diabetes mellitus	2.32e-06	5.35e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—MTHFR—type 2 diabetes mellitus	2.31e-06	5.33e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.31e-06	5.32e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.27e-06	5.24e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	2.27e-06	5.24e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	2.27e-06	5.24e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PPARA—type 2 diabetes mellitus	2.27e-06	5.23e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—ALB—type 2 diabetes mellitus	2.26e-06	5.22e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.26e-06	5.21e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CD36—type 2 diabetes mellitus	2.26e-06	5.21e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	2.23e-06	5.15e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.23e-06	5.14e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	2.21e-06	5.09e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.21e-06	5.09e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AGT—type 2 diabetes mellitus	2.2e-06	5.07e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTGS2—type 2 diabetes mellitus	2.19e-06	5.06e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.17e-06	5.02e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	2.17e-06	5e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	2.17e-06	5e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	2.17e-06	5e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—NOS3—type 2 diabetes mellitus	2.16e-06	4.99e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3R1—type 2 diabetes mellitus	2.16e-06	4.99e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	2.16e-06	4.98e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	2.16e-06	4.98e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CALM1—type 2 diabetes mellitus	2.16e-06	4.98e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	2.16e-06	4.97e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	2.16e-06	4.97e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	2.16e-06	4.97e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—APOE—type 2 diabetes mellitus	2.15e-06	4.96e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—MTHFR—type 2 diabetes mellitus	2.14e-06	4.94e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	2.13e-06	4.91e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—APOA1—type 2 diabetes mellitus	2.13e-06	4.91e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	2.12e-06	4.89e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CTGF—type 2 diabetes mellitus	2.12e-06	4.88e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	2.11e-06	4.86e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	2.11e-06	4.86e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	2.11e-06	4.86e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	2.11e-06	4.86e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PPARA—type 2 diabetes mellitus	2.1e-06	4.84e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	2.1e-06	4.84e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.09e-06	4.83e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.08e-06	4.8e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.07e-06	4.77e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	2.06e-06	4.76e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	2.06e-06	4.75e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.06e-06	4.74e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	2.05e-06	4.73e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AGT—type 2 diabetes mellitus	2.03e-06	4.69e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	2.03e-06	4.69e-05	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	2.03e-06	4.67e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	2.02e-06	4.66e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	2.02e-06	4.66e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CALM1—type 2 diabetes mellitus	2e-06	4.61e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	1.99e-06	4.6e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—APOE—type 2 diabetes mellitus	1.99e-06	4.6e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	1.98e-06	4.57e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTGS2—type 2 diabetes mellitus	1.98e-06	4.57e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.98e-06	4.57e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	1.97e-06	4.55e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	1.97e-06	4.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.97e-06	4.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.97e-06	4.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.97e-06	4.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.97e-06	4.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	1.96e-06	4.52e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	1.96e-06	4.52e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.95e-06	4.51e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	1.95e-06	4.5e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	1.95e-06	4.5e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.92e-06	4.43e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	1.91e-06	4.41e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.9e-06	4.39e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	1.9e-06	4.39e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.9e-06	4.38e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.89e-06	4.36e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.89e-06	4.36e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.89e-06	4.36e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.89e-06	4.36e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	1.88e-06	4.34e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	1.88e-06	4.34e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	1.87e-06	4.32e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GCG—type 2 diabetes mellitus	1.87e-06	4.31e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	1.87e-06	4.31e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.85e-06	4.28e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	1.84e-06	4.24e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.84e-06	4.24e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.8e-06	4.15e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.8e-06	4.15e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.77e-06	4.08e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.76e-06	4.07e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.76e-06	4.07e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.76e-06	4.07e-05	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AKT1—type 2 diabetes mellitus	1.76e-06	4.06e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	1.74e-06	4e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.73e-06	4e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.73e-06	3.98e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.72e-06	3.96e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.71e-06	3.94e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.71e-06	3.94e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—INS—type 2 diabetes mellitus	1.7e-06	3.93e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.69e-06	3.9e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	1.69e-06	3.89e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—SRC—type 2 diabetes mellitus	1.68e-06	3.88e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.68e-06	3.87e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.67e-06	3.84e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.64e-06	3.78e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	1.64e-06	3.78e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	1.64e-06	3.78e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	1.62e-06	3.74e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.62e-06	3.74e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.61e-06	3.72e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	1.61e-06	3.72e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.61e-06	3.72e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	1.61e-06	3.72e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GNB3—type 2 diabetes mellitus	1.61e-06	3.72e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.61e-06	3.72e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	1.6e-06	3.7e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.6e-06	3.68e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.6e-06	3.68e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	1.59e-06	3.67e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CAT—type 2 diabetes mellitus	1.58e-06	3.65e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	1.56e-06	3.6e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.56e-06	3.59e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.55e-06	3.57e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	1.54e-06	3.56e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—APOB—type 2 diabetes mellitus	1.54e-06	3.54e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.53e-06	3.53e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.53e-06	3.53e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	1.5e-06	3.47e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	1.5e-06	3.46e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	1.49e-06	3.45e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	1.49e-06	3.44e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.49e-06	3.44e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	1.47e-06	3.4e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	1.47e-06	3.4e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—LPL—type 2 diabetes mellitus	1.47e-06	3.38e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	1.44e-06	3.33e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	1.44e-06	3.32e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	1.44e-06	3.31e-05	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AKT1—type 2 diabetes mellitus	1.44e-06	3.31e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—GPX1—type 2 diabetes mellitus	1.43e-06	3.3e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.41e-06	3.26e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.41e-06	3.26e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.4e-06	3.24e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	1.4e-06	3.23e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CD36—type 2 diabetes mellitus	1.39e-06	3.21e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.39e-06	3.2e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	1.38e-06	3.19e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	1.38e-06	3.17e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	1.37e-06	3.15e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.35e-06	3.1e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	1.33e-06	3.06e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	1.32e-06	3.05e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	1.32e-06	3.04e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.32e-06	3.04e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	1.31e-06	3.03e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.31e-06	3.02e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	1.3e-06	3.01e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPARA—type 2 diabetes mellitus	1.3e-06	2.99e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	1.3e-06	2.99e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.28e-06	2.96e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	1.26e-06	2.91e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.26e-06	2.9e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	1.26e-06	2.9e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AGT—type 2 diabetes mellitus	1.25e-06	2.89e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.25e-06	2.89e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	1.24e-06	2.86e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	1.24e-06	2.85e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CALM1—type 2 diabetes mellitus	1.23e-06	2.85e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—APOE—type 2 diabetes mellitus	1.23e-06	2.84e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.22e-06	2.82e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	1.22e-06	2.82e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.22e-06	2.82e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—APOA1—type 2 diabetes mellitus	1.22e-06	2.8e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.21e-06	2.78e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.2e-06	2.77e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.18e-06	2.71e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.17e-06	2.7e-05	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AKT1—type 2 diabetes mellitus	1.17e-06	2.7e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.16e-06	2.67e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.14e-06	2.63e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.14e-06	2.62e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.13e-06	2.6e-05	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AKT1—type 2 diabetes mellitus	1.1e-06	2.54e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.1e-06	2.54e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.08e-06	2.49e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.08e-06	2.49e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.08e-06	2.48e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	1.08e-06	2.48e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PPARG—type 2 diabetes mellitus	1.07e-06	2.47e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.06e-06	2.46e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.06e-06	2.45e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	1.06e-06	2.44e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—INS—type 2 diabetes mellitus	1.05e-06	2.42e-05	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	1.04e-06	2.41e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.03e-06	2.37e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.01e-06	2.33e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.01e-06	2.32e-05	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AKT1—type 2 diabetes mellitus	9.95e-07	2.3e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	9.95e-07	2.29e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	9.68e-07	2.23e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	9.38e-07	2.16e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	9.26e-07	2.14e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	9.26e-07	2.14e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	9.21e-07	2.12e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NOS3—type 2 diabetes mellitus	9.21e-07	2.12e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—INS—type 2 diabetes mellitus	9.2e-07	2.12e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	8.76e-07	2.02e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	8.6e-07	1.98e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	8.47e-07	1.95e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	8.44e-07	1.95e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	8.42e-07	1.94e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	8.07e-07	1.86e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	8.07e-07	1.86e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	7.88e-07	1.82e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	7.54e-07	1.74e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	7.54e-07	1.74e-05	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	7.41e-07	1.71e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	7.38e-07	1.7e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	6.89e-07	1.59e-05	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	6.86e-07	1.58e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	4.26e-07	9.82e-06	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AKT1—type 2 diabetes mellitus	4.23e-07	9.77e-06	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	3.71e-07	8.56e-06	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	3.47e-07	7.99e-06	CbGpPWpGaD
